• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Effects of testosterone on lean mass gain in elderly men: systematic review with meta-analysis of controlled and randomized studies.睾酮对老年男性瘦体重增加的影响:对照和随机研究的系统评价与荟萃分析
Age (Dordr). 2015 Feb;37(1):9742. doi: 10.1007/s11357-014-9742-0. Epub 2015 Feb 1.
2
Androgens (dehydroepiandrosterone or testosterone) for women undergoing assisted reproduction.雄激素(脱氢表雄酮或睾酮)用于接受辅助生殖的女性。
Cochrane Database Syst Rev. 2015 Nov 26;2015(11):CD009749. doi: 10.1002/14651858.CD009749.pub2.
3
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
4
Pharmacological interventions for those who have sexually offended or are at risk of offending.针对有性犯罪行为或有性犯罪风险者的药物干预措施。
Cochrane Database Syst Rev. 2015 Feb 18;2015(2):CD007989. doi: 10.1002/14651858.CD007989.pub2.
5
Pre-operative endometrial thinning agents before endometrial destruction for heavy menstrual bleeding.对于月经过多患者,在进行子宫内膜破坏术前使用的术前子宫内膜减薄剂。
Cochrane Database Syst Rev. 2013 Nov 15;2013(11):CD010241. doi: 10.1002/14651858.CD010241.pub2.
6
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状Meta分析。
Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3.
7
Sertindole for schizophrenia.用于治疗精神分裂症的舍吲哚。
Cochrane Database Syst Rev. 2005 Jul 20;2005(3):CD001715. doi: 10.1002/14651858.CD001715.pub2.
8
Dehydroepiandrosterone for women in the peri- or postmenopausal phase.绝经前后阶段女性使用脱氢表雄酮。
Cochrane Database Syst Rev. 2015 Jan 22;1(1):CD011066. doi: 10.1002/14651858.CD011066.pub2.
9
Testosterone and cardiovascular risk in men: a systematic review and meta-analysis of randomized placebo-controlled trials.男性睾酮与心血管风险:随机安慰剂对照试验的系统评价与荟萃分析
Mayo Clin Proc. 2007 Jan;82(1):29-39. doi: 10.4065/82.1.29.
10
Effects of testosterone on body composition, bone metabolism and serum lipid profile in middle-aged men: a meta-analysis.睾酮对中年男性身体成分、骨代谢和血脂谱的影响:一项荟萃分析。
Clin Endocrinol (Oxf). 2005 Sep;63(3):280-93. doi: 10.1111/j.1365-2265.2005.02339.x.

引用本文的文献

1
Rethinking Osteoporosis Drugs: Can We Simultaneously Address Sarcopenia?重新思考骨质疏松症药物:我们能否同时解决肌肉减少症问题?
Int J Mol Sci. 2025 Jul 18;26(14):6924. doi: 10.3390/ijms26146924.
2
Benefits of Cardiac Rehabilitation: Mechanisms to Restore Function and Clinical Impact.心脏康复的益处:恢复功能的机制及临床影响
Circ Res. 2025 Jul 7;137(2):255-272. doi: 10.1161/CIRCRESAHA.125.325705. Epub 2025 Jul 3.
3
Anabolic steroid consumption among gym-goers in Amman: knowledge, attitudes, and behaviors.安曼健身者中合成代谢类固醇的使用情况:知识、态度及行为
Front Sports Act Living. 2024 Aug 29;6:1404551. doi: 10.3389/fspor.2024.1404551. eCollection 2024.
4
Testosterone therapy for functional hypogonadism in middle-aged and elderly males: current evidence and future perspectives.中老年男性功能性性腺功能减退症的睾酮治疗:当前证据与未来展望。
Hormones (Athens). 2024 Dec;23(4):801-817. doi: 10.1007/s42000-024-00587-2. Epub 2024 Jul 26.
5
Management of male obesity-related secondary hypogonadism: A clinical update.男性肥胖相关性继发性性腺功能减退的管理:临床最新进展
World J Exp Med. 2024 Jun 20;14(2):93689. doi: 10.5493/wjem.v14.i2.93689.
6
The Association Between Sarcopenia and Diabetes: From Pathophysiology Mechanism to Therapeutic Strategy.肌肉减少症与糖尿病之间的关联:从病理生理机制到治疗策略
Diabetes Metab Syndr Obes. 2023 May 30;16:1541-1554. doi: 10.2147/DMSO.S410834. eCollection 2023.
7
Use of weight loss medications in relation with prostate, colorectal and male breast cancers among older men: SEER-Medicare 2007-2015.老年人中使用减肥药物与前列腺癌、结直肠癌和男性乳腺癌的关系:SEER-医疗保险 2007-2015 年。
J Cancer Res Clin Oncol. 2023 Sep;149(11):8255-8265. doi: 10.1007/s00432-023-04778-z. Epub 2023 Apr 17.
8
Adult- and late-onset male hypogonadism: the clinical practice guidelines of the Italian Society of Andrology and Sexual Medicine (SIAMS) and the Italian Society of Endocrinology (SIE).成人和迟发性男性性腺功能减退症:意大利男科学和性医学学会 (SIAMS) 和意大利内分泌学会 (SIE) 的临床实践指南。
J Endocrinol Invest. 2022 Dec;45(12):2385-2403. doi: 10.1007/s40618-022-01859-7. Epub 2022 Aug 26.
9
Testosterone undecanoate administration prevents declines in fat-free mass but not physical performance during simulated multi-stressor military operations.十一酸睾酮给药可预防去脂体重下降,但不能预防模拟多应激军事行动期间的身体机能下降。
J Appl Physiol (1985). 2022 Aug 1;133(2):426-442. doi: 10.1152/japplphysiol.00190.2022. Epub 2022 Jul 7.
10
The Role of Testosterone in the Elderly: What Do We Know?睾酮在老年人中的作用:我们了解多少?
Int J Mol Sci. 2022 Mar 24;23(7):3535. doi: 10.3390/ijms23073535.

本文引用的文献

1
Translational studies in older men using testosterone to treat sarcopenia.在老年男性中使用睾酮治疗肌肉减少症的转化研究。
Trans Am Clin Climatol Assoc. 2014;125:27-42; discussion 42-4.
2
Effect of hormone replacement therapy on cardiovascular outcomes: a meta-analysis of randomized controlled trials.激素替代疗法对心血管结局的影响:随机对照试验的荟萃分析。
PLoS One. 2013 May 8;8(5):e62329. doi: 10.1371/journal.pone.0062329. Print 2013.
3
Testosterone therapy and cardiovascular events among men: a systematic review and meta-analysis of placebo-controlled randomized trials.睾酮治疗与男性心血管事件:安慰剂对照随机试验的系统评价和荟萃分析。
BMC Med. 2013 Apr 18;11:108. doi: 10.1186/1741-7015-11-108.
4
Androgen deficiency in older men: indications, advantages, and pitfalls of testosterone replacement therapy.老年男性雄激素缺乏症:睾酮替代治疗的适应证、优势及陷阱。
Cleve Clin J Med. 2012 Nov;79(11):797-806. doi: 10.3949/ccjm.79a.12010.
5
Androgens affect myogenesis in vitro and increase local IGF-1 expression.雄激素在体外影响成肌生成作用,并增加局部 IGF-1 的表达。
Med Sci Sports Exerc. 2012 Apr;44(4):610-5. doi: 10.1249/MSS.0b013e318237c5c0.
6
A randomized pilot study of monthly cycled testosterone replacement or continuous testosterone replacement versus placebo in older men.一项关于每月循环睾酮替代治疗或连续睾酮替代治疗与安慰剂治疗老年男性的随机试点研究。
J Clin Endocrinol Metab. 2011 Nov;96(11):E1831-7. doi: 10.1210/jc.2011-1262. Epub 2011 Aug 24.
7
Protection against dexamethasone-induced muscle atrophy is related to modulation by testosterone of FOXO1 and PGC-1α.雄激素通过调节 FOXO1 和 PGC-1α 对地塞米松诱导的肌肉萎缩起保护作用。
Biochem Biophys Res Commun. 2010 Dec 17;403(3-4):473-8. doi: 10.1016/j.bbrc.2010.11.061. Epub 2010 Nov 19.
8
Testosterone-induced hypertrophy of L6 myoblasts is dependent upon Erk and mTOR.睾酮诱导的 L6 成肌细胞肥大依赖于 Erk 和 mTOR。
Biochem Biophys Res Commun. 2010 Oct 1;400(4):679-83. doi: 10.1016/j.bbrc.2010.08.127. Epub 2010 Sep 9.
9
Effects of transdermal testosterone on bone and muscle in older men with low bioavailable testosterone levels, low bone mass, and physical frailty.经皮睾酮对低生物利用度睾酮水平、低骨量和身体虚弱的老年男性的骨骼和肌肉的影响。
J Am Geriatr Soc. 2010 Jun;58(6):1134-43. doi: 10.1111/j.1532-5415.2010.02865.x.
10
Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline.男性雄激素缺乏综合征的睾酮治疗:内分泌学会临床实践指南。
J Clin Endocrinol Metab. 2010 Jun;95(6):2536-59. doi: 10.1210/jc.2009-2354.

睾酮对老年男性瘦体重增加的影响:对照和随机研究的系统评价与荟萃分析

Effects of testosterone on lean mass gain in elderly men: systematic review with meta-analysis of controlled and randomized studies.

作者信息

Neto Walter Krause, Gama Eliane Florencio, Rocha Leandro Yanase, Ramos Carla Cristina, Taets Wagner, Scapini Katia Bilhar, Ferreira Janaina B, Rodrigues Bruno, Caperuto Érico

机构信息

Laboratory of Morphoquantitative Studies and Immunohistochemistry, Department of Physical Education, São Judas Tadeu University, São Paulo, SP, Brazil,

出版信息

Age (Dordr). 2015 Feb;37(1):9742. doi: 10.1007/s11357-014-9742-0. Epub 2015 Feb 1.

DOI:10.1007/s11357-014-9742-0
PMID:25637335
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4312307/
Abstract

The objective of this study was to evaluate the effects of steroid anabolic androgenic hormones use on lean mass gain in elderly men through a systematic review with a meta-analysis of randomized controlled studies. We systematically searched PubMed database until 4th October 2013. We included randomized placebo-controlled trials (RCT) that studied testosterone replacement therapy in men over 60 years of age, with total testosterone levels ≤550 ng/dl, observing gains in weight, lean mass tissue and fat mass as outcome. We excluded duplicated studies, studies which mixed men and women, and studies using weak androgens such as dehydroepiandrosterone or androstenedione. The initial search yielded 2681 articles, of which 26 were selected for full text analysis. In the end, 11 studies were included. However, 3 studies were not included in the meta-analysis. Meta-analysis showed that mean weight increased (lean mass), ranging from 1.65 (95 % CI, 1.61-1.69) to 6.20 (95 % CI, 5.22-7.18) kg, although it was heterogeneous (I (2) = 98 %). Effect estimate was 3.59 [2.38-4.81]. Androgen therapy decreased fat mass; effect estimate was -1.78 [-2.57, -0.99] that analysis had also a high level of heterogeneity (I (2) = 81 %). The results suggest that testosterone replacement therapy is able to increase muscle mass in elderly men and that is affected by the time that the treatment is carried out and the method of administration of the drug.

摘要

本研究的目的是通过对随机对照研究进行系统评价和荟萃分析,评估使用类固醇合成代谢雄激素对老年男性瘦体重增加的影响。我们系统检索了截至2013年10月4日的PubMed数据库。我们纳入了随机安慰剂对照试验(RCT),这些试验研究了60岁以上、总睾酮水平≤550 ng/dl男性的睾酮替代疗法,并观察体重、瘦体重组织和脂肪量的增加作为结局。我们排除了重复研究、混合了男性和女性的研究,以及使用脱氢表雄酮或雄烯二酮等弱雄激素的研究。初步检索得到2681篇文章,其中26篇被选作全文分析。最终,纳入了11项研究。然而,3项研究未纳入荟萃分析。荟萃分析显示,平均体重增加(瘦体重),范围从1.65(95%CI,1.61 - 1.69)至6.20(95%CI,5.22 - 7.18)kg,尽管存在异质性(I(2)=98%)。效应估计值为3.59[2.38 - 4.81]。雄激素治疗减少了脂肪量;效应估计值为 - 1.78[-2.57,-0.99],该分析也具有高度异质性(I(2)=81%)。结果表明,睾酮替代疗法能够增加老年男性的肌肉量,且这受治疗实施时间和药物给药方法的影响。